CG Oncology (CGON) News Today $28.67 +0.65 (+2.32%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period CG Oncology (NASDAQ:CGON) Shares Down 4.3% - Should You Sell?CG Oncology (NASDAQ:CGON) Shares Down 4.3% - Here's What HappenedDecember 19 at 1:47 PM | marketbeat.comState Street Corp Raises Stake in CG Oncology, Inc. (NASDAQ:CGON)State Street Corp raised its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 73.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,700,653 shares of the company's stock after purchasing an adDecember 19 at 3:32 AM | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Director Sells $19,600,000.00 in StockDecember 18 at 5:22 AM | insidertrades.comCG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by Franklin Resources Inc.Franklin Resources Inc. grew its stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 8.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,230,193 shares of the company'sDecember 18 at 4:54 AM | marketbeat.comHong Fang Song Sells 700,000 Shares of CG Oncology, Inc. (NASDAQ:CGON) StockCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) Director Hong Fang Song sold 700,000 shares of the business's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $28.00, for a total value of $19,600,000.00. Following the sale, the director now owns 3,003,931 shares in the company, valued at approximately $84,110,068. The trade was a 18.90 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.December 17, 2024 | marketbeat.comCG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesDecember 17, 2024 | markets.businessinsider.comCG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesDecember 16, 2024 | globenewswire.comFinancial Review: LENZ Therapeutics (NASDAQ:LENZ) vs. CG Oncology (NASDAQ:CGON)December 16, 2024 | americanbankingnews.comJane Street Group LLC Grows Position in CG Oncology, Inc. (NASDAQ:CGON)Jane Street Group LLC raised its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 240.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 195,951 shares of the company's stock after buying an additional 138,400 shares durDecember 15, 2024 | marketbeat.comCG Oncology (NASDAQ:CGON) Sees Unusually-High Trading Volume - Here's What HappenedDecember 15, 2024 | americanbankingnews.comCG Oncology 8M share Secondary priced at $28.00December 14, 2024 | markets.businessinsider.comWellington Management Group LLP Has $19.25 Million Stake in CG Oncology, Inc. (NASDAQ:CGON)Wellington Management Group LLP raised its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 153.4% during the third quarter, according to its most recent filing with the SEC. The firm owned 510,219 shares of the company's stock after purchasing an additional 308,852 shares during the peDecember 14, 2024 | marketbeat.comCG Oncology: Positive Phase 3 Outcome Could Lead To BLA Of CretostimogeneDecember 13, 2024 | seekingalpha.comCG Oncology (NASDAQ:CGON) Sees Unusually-High Trading Volume - Should You Buy?CG Oncology (NASDAQ:CGON) Sees Strong Trading Volume - Here's What HappenedDecember 13, 2024 | marketbeat.comFmr LLC Raises Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON)Fmr LLC boosted its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 83,581.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 145,606 shares of the company's stock after purchasing an additionalDecember 13, 2024 | marketbeat.comCG Oncology Announces Pricing of Public OfferingDecember 12, 2024 | globenewswire.comNeo Ivy Capital Management Invests $1.12 Million in CG Oncology, Inc. (NASDAQ:CGON)Neo Ivy Capital Management bought a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 29,678 shares of the company's stock, valued at approximately $1,120,000. Other iDecember 12, 2024 | marketbeat.comCG Oncology Announces Proposed Public OfferingDecember 11, 2024 | globenewswire.comCG Oncology, Inc. (NASDAQ:CGON) Stake Boosted by BNP Paribas Financial MarketsBNP Paribas Financial Markets increased its stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 876.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,660 shares of the company's stock after puDecember 11, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $14.33 Million Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON)Charles Schwab Investment Management Inc. boosted its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 114.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 379,664 shares of the companyDecember 9, 2024 | marketbeat.comLeonard E. Post Sells 1,000 Shares of CG Oncology, Inc. (NASDAQ:CGON) StockDecember 7, 2024 | insidertrades.comCG Oncology, Inc. (NASDAQ:CGON) Director Leonard E. Post Sells 1,000 SharesCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) Director Leonard E. Post sold 1,000 shares of CG Oncology stock in a transaction on Friday, December 6th. The stock was sold at an average price of $34.54, for a total value of $34,540.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.December 6, 2024 | marketbeat.comPromising Clinical Results and Strategic Positioning: CG Oncology Recommended as a BuyDecember 6, 2024 | markets.businessinsider.comDemystifying CG Oncology: Insights From 7 Analyst ReviewsDecember 6, 2024 | benzinga.comHealth Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancerDecember 6, 2024 | reuters.comCG Oncology's (CGON) Outperform Rating Reaffirmed at Royal Bank of CanadaRoyal Bank of Canada reaffirmed an "outperform" rating and issued a $66.00 price target on shares of CG Oncology in a report on Friday.December 6, 2024 | marketbeat.comCG Oncology's (CGON) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $75.00 target price on shares of CG Oncology in a research report on Friday.December 6, 2024 | marketbeat.comSUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship AwardDecember 6, 2024 | globenewswire.comPoint72 Asset Management L.P. Has $28.15 Million Holdings in CG Oncology, Inc. (NASDAQ:CGON)Point72 Asset Management L.P. boosted its position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 575.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 746,063 shares of the company'sDecember 6, 2024 | marketbeat.comPolar Asset Management Partners Inc. Takes $973,000 Position in CG Oncology, Inc. (NASDAQ:CGON)Polar Asset Management Partners Inc. purchased a new position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 25,800 shares of the company's stock, valued at approximately $973,000. SeveralDecember 6, 2024 | marketbeat.comJanus Henderson Group PLC Boosts Stake in CG Oncology, Inc. (NASDAQ:CGON)Janus Henderson Group PLC raised its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 7.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,526,534 shares of the company's stock after buying an aDecember 6, 2024 | marketbeat.comCG Oncology, Inc.: A Strong Buy on Promising NMIBC Treatment CretostimogeneDecember 6, 2024 | markets.businessinsider.comBuy Rating Recommended for CG Oncology Due to Promising Phase 3 Trial Results of CretostimogeneDecember 6, 2024 | markets.businessinsider.comCG Oncology Reports Promising Phase 3 Trial ResultsDecember 5, 2024 | tipranks.comGroundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder CancerDecember 5, 2024 | globenewswire.comCG Oncology, Inc. (NASDAQ:CGON) Given Average Rating of "Buy" by AnalystsCG Oncology, Inc. (NASDAQ:CGON - Get Free Report) has received a consensus rating of "Buy" from the nine research firms that are covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The averagDecember 5, 2024 | marketbeat.comHighVista Strategies LLC Invests $594,000 in CG Oncology, Inc. (NASDAQ:CGON)HighVista Strategies LLC acquired a new stake in CG Oncology, Inc. (NASDAQ:CGON - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,734 shares of the company's stock, valued at approximately $594,000December 3, 2024 | marketbeat.comArrowMark Colorado Holdings LLC Purchases 34,131 Shares of CG Oncology, Inc. (NASDAQ:CGON)ArrowMark Colorado Holdings LLC lifted its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 17.4% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 230,390 shares of the company's stock after acquiring an additional 34,131 shares durinDecember 3, 2024 | marketbeat.comBraidwell LP Sells 138,632 Shares of CG Oncology, Inc. (NASDAQ:CGON)Braidwell LP cut its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 4.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,170,875 shares of the company's stock after selling 138,632 shares during the period. CG Oncology accounts forNovember 29, 2024 | marketbeat.comAlly Bridge Group NY LLC Acquires 88,390 Shares of CG Oncology, Inc. (NASDAQ:CGON)Ally Bridge Group NY LLC lifted its holdings in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 50.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 263,266 shares of the company's stock after purchasing an additional 88,390 shares during the quarter. CG ONovember 28, 2024 | marketbeat.comCG Oncology, Inc. (NASDAQ:CGON) Stock Position Lessened by Yu FanYu Fan decreased its position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 89.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 163,456 shares of the company's stock after selling 1,414,888 shares durNovember 28, 2024 | marketbeat.comABG WTT Global Life Science Capital Partners GP Ltd Sells 419,975 Shares of CG Oncology, Inc. (NASDAQ:CGON)ABG WTT Global Life Science Capital Partners GP Ltd lowered its position in CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 45.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 495,526 shares of the company's stocNovember 28, 2024 | marketbeat.comCG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual MeetingNovember 20, 2024 | markets.businessinsider.comShort Interest in CG Oncology, Inc. (NASDAQ:CGON) Drops By 6.0%CG Oncology, Inc. (NASDAQ:CGON - Get Free Report) was the target of a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 5,600,000 shares, a decrease of 6.0% from the October 15th total of 5,960,000 shares. Currently, 13.9% of the company's shares are short sold. Based on an average daily volume of 638,000 shares, the short-interest ratio is currently 8.8 days.November 18, 2024 | marketbeat.comCG Oncology FY2024 EPS Estimate Lifted by Cantor FitzgeraldCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Research analysts at Cantor Fitzgerald raised their FY2024 earnings per share (EPS) estimates for shares of CG Oncology in a research report issued on Wednesday, November 13th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company wilNovember 18, 2024 | marketbeat.comLos Angeles Capital Management LLC Takes Position in CG Oncology, Inc. (NASDAQ:CGON)Los Angeles Capital Management LLC purchased a new stake in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,052 shares oNovember 16, 2024 | marketbeat.comFY2024 EPS Estimates for CG Oncology Lifted by HC WainwrightCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Analysts at HC Wainwright increased their FY2024 EPS estimates for CG Oncology in a research note issued to investors on Wednesday, November 13th. HC Wainwright analyst A. Maldonado now expects that the company will post earnings of ($1.33) per sharNovember 15, 2024 | marketbeat.comCG Oncology FY2024 EPS Forecast Increased by Lifesci CapitalCG Oncology, Inc. (NASDAQ:CGON - Free Report) - Research analysts at Lifesci Capital upped their FY2024 earnings estimates for CG Oncology in a report issued on Tuesday, November 12th. Lifesci Capital analyst S. Slutsky now expects that the company will post earnings of ($1.41) per share for theNovember 15, 2024 | marketbeat.comCG Oncology’s Financial Results and Clinical DevelopmentsNovember 14, 2024 | tipranks.comCG Oncology (NASDAQ:CGON) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPSCG Oncology (NASDAQ:CGON - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.06. The firm had revenue of $0.04 million for the quarter, compared to analyst estimates of $0.30 million.November 13, 2024 | marketbeat.com Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now CGON Media Mentions By Week CGON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGON News Sentiment▼0.840.61▲Average Medical News Sentiment CGON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGON Articles This Week▼123▲CGON Articles Average Week Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Revolution Medicines News Today Lantheus News Today Nuvalent News Today Blueprint Medicines News Today Legend Biotech News Today Elanco Animal Health News Today Cytokinetics News Today TG Therapeutics News Today Viking Therapeutics News Today BridgeBio Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGON) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGON Stock Alerts